BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26825694)

  • 1. Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?
    Chung SS
    Curr Opin Hematol; 2016 Mar; 23(2):79-87. PubMed ID: 26825694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
    Nazha A; Sekeres MA; Gore SD; Zeidan AM
    Oncologist; 2015 Sep; 20(9):1069-76. PubMed ID: 26194858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.
    Kennedy JA; Ebert BL
    J Clin Oncol; 2017 Mar; 35(9):968-974. PubMed ID: 28297619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
    Iacobucci I; Mullighan CG
    Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular pathogenesis of the myelodysplastic syndromes.
    Pellagatti A; Boultwood J
    Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.
    Tothova Z; Steensma DP; Ebert BL
    Clin Cancer Res; 2013 Apr; 19(7):1637-43. PubMed ID: 23329810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic and molecular pathogenesis of myelodysplastic syndromes.
    Shallis RM; Ahmad R; Zeidan AM
    Eur J Haematol; 2018 Sep; 101(3):260-271. PubMed ID: 29742289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation-Driven Therapy in MDS.
    Swoboda DM; Sallman DA
    Curr Hematol Malig Rep; 2019 Dec; 14(6):550-560. PubMed ID: 31760573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes.
    Itzykson R; Kosmider O; Fenaux P
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):355-64. PubMed ID: 24507812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of molecular genetic diversity in myelodysplastic syndromes.
    Bejar R
    Curr Opin Hematol; 2017 Mar; 24(2):73-78. PubMed ID: 27875374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
    Sperling AS; Gibson CJ; Ebert BL
    Nat Rev Cancer; 2017 Jan; 17(1):5-19. PubMed ID: 27834397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic Syndromes: Diagnosis and Treatment.
    Steensma DP
    Mayo Clin Proc; 2015 Jul; 90(7):969-83. PubMed ID: 26141335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
    Schratz KE; DeZern AE
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of myelodysplastic syndromes: new insights.
    Graubert T; Walter MJ
    Hematology Am Soc Hematol Educ Program; 2011; 2011():543-9. PubMed ID: 22160087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.
    Steensma DP
    Blood; 2018 Oct; 132(16):1657-1663. PubMed ID: 30185432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights.
    Cherian S; Bagg A
    Hematology; 2006 Feb; 11(1):1-13. PubMed ID: 16522543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
    Nazha A; Sekeres MA
    Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.
    Nassereddine S; Nishihori T; Padron E; Mahfouz R; Bazarbachi A; Komrokji RS; Kharfan-Dabaja MA
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):7-13. PubMed ID: 27771290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?
    Thol F; Platzbecker U
    Blood Adv; 2019 Nov; 3(21):3449-3453. PubMed ID: 31714960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.